Cargando…

Correlation of hair risperidone concentration and serum level among patients with schizophrenia

BACKGROUND: Risperidone (RSP) has a rapid onset in vivo, low dosage and high plasma protein binding rate, therefore therapeutic drug monitoring (TDM) is needed to ensure safety in clinical treatment. However, compared with blood, hair is non-invasive, safe, non-infectious and easy to transport and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiujia, Wang, Lihua, Yang, Fuzhong, Ren, Juanjuan, Jiang, Ping, Liu, Hongmei, Li, Huafang, Li, Chunbo, Zhang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551431/
https://www.ncbi.nlm.nih.gov/pubmed/31179425
http://dx.doi.org/10.1136/gpsych-2018-100042
_version_ 1783424386715353088
author Sun, Xiujia
Wang, Lihua
Yang, Fuzhong
Ren, Juanjuan
Jiang, Ping
Liu, Hongmei
Li, Huafang
Li, Chunbo
Zhang, Chen
author_facet Sun, Xiujia
Wang, Lihua
Yang, Fuzhong
Ren, Juanjuan
Jiang, Ping
Liu, Hongmei
Li, Huafang
Li, Chunbo
Zhang, Chen
author_sort Sun, Xiujia
collection PubMed
description BACKGROUND: Risperidone (RSP) has a rapid onset in vivo, low dosage and high plasma protein binding rate, therefore therapeutic drug monitoring (TDM) is needed to ensure safety in clinical treatment. However, compared with blood, hair is non-invasive, safe, non-infectious and easy to transport and store. AIMS: This study aims to investigate the correlations among the drug concentrations of RSP in hair and serum, which provides an experimental basis to explore hair as a novel biomaterial to meet the needs of clinical detection. METHODS: 34 patients with schizophrenia treated with RSP for more than 3 months were enrolled in this study. About 1 cm section of hair near the scalp was taken from the subjects, pretreated and detected by liquid chromatography-mass spectrometry. A correlation analysis was conducted among the drug concentrations in hair, the serum concentrations and the daily dosage. The data were analysed using SPSS 20.0 software. RESULTS : There was significant correlation between the hair concentration of RSP (two-tailed test, r=0.440, p=0.009) with the serum concentration of RSP, and the hair concentration of 9-hydroxyrisperidone (9-HR) with the serum concentration of 9-HR had no significant correlation (two-tailed test, r=−0.217, p=0.217); the total concentration of the RSP and 9-HR had no significant correlation between hair and serum (r=0.227, p=0.196). The dosage had no statistically significant correlation with the concentration of RSP in hair (r=0.207, p=0.241), 9-HR in hair (r=−0.194, p=0.271) and the total concentration of RSP and 9-HR in hair (r=0.188, p=0.288). There was no statistical correlation between the dosage and the concentration of RSP in serum (r=−0.059, p=0.741), but significant correlation between the dosage and 9-HR in serum (r=0.581 p<0.001) was found, and the correlation between the dosage and the total concentration of the two drugs RSP and 9-HR in serum was also significant (r=0.437, p=0.01). CONCLUSION: The correlation analysis showed that the concentration of RSP in hair was statistically significant with the serum RSP concentration. In this study, we provided some experimental basis for hair as a new biomaterial to monitor the therapeutic drug concentration.
format Online
Article
Text
id pubmed-6551431
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65514312019-06-07 Correlation of hair risperidone concentration and serum level among patients with schizophrenia Sun, Xiujia Wang, Lihua Yang, Fuzhong Ren, Juanjuan Jiang, Ping Liu, Hongmei Li, Huafang Li, Chunbo Zhang, Chen Gen Psychiatr Original Research BACKGROUND: Risperidone (RSP) has a rapid onset in vivo, low dosage and high plasma protein binding rate, therefore therapeutic drug monitoring (TDM) is needed to ensure safety in clinical treatment. However, compared with blood, hair is non-invasive, safe, non-infectious and easy to transport and store. AIMS: This study aims to investigate the correlations among the drug concentrations of RSP in hair and serum, which provides an experimental basis to explore hair as a novel biomaterial to meet the needs of clinical detection. METHODS: 34 patients with schizophrenia treated with RSP for more than 3 months were enrolled in this study. About 1 cm section of hair near the scalp was taken from the subjects, pretreated and detected by liquid chromatography-mass spectrometry. A correlation analysis was conducted among the drug concentrations in hair, the serum concentrations and the daily dosage. The data were analysed using SPSS 20.0 software. RESULTS : There was significant correlation between the hair concentration of RSP (two-tailed test, r=0.440, p=0.009) with the serum concentration of RSP, and the hair concentration of 9-hydroxyrisperidone (9-HR) with the serum concentration of 9-HR had no significant correlation (two-tailed test, r=−0.217, p=0.217); the total concentration of the RSP and 9-HR had no significant correlation between hair and serum (r=0.227, p=0.196). The dosage had no statistically significant correlation with the concentration of RSP in hair (r=0.207, p=0.241), 9-HR in hair (r=−0.194, p=0.271) and the total concentration of RSP and 9-HR in hair (r=0.188, p=0.288). There was no statistical correlation between the dosage and the concentration of RSP in serum (r=−0.059, p=0.741), but significant correlation between the dosage and 9-HR in serum (r=0.581 p<0.001) was found, and the correlation between the dosage and the total concentration of the two drugs RSP and 9-HR in serum was also significant (r=0.437, p=0.01). CONCLUSION: The correlation analysis showed that the concentration of RSP in hair was statistically significant with the serum RSP concentration. In this study, we provided some experimental basis for hair as a new biomaterial to monitor the therapeutic drug concentration. BMJ Publishing Group 2019-02-20 /pmc/articles/PMC6551431/ /pubmed/31179425 http://dx.doi.org/10.1136/gpsych-2018-100042 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Original Research
Sun, Xiujia
Wang, Lihua
Yang, Fuzhong
Ren, Juanjuan
Jiang, Ping
Liu, Hongmei
Li, Huafang
Li, Chunbo
Zhang, Chen
Correlation of hair risperidone concentration and serum level among patients with schizophrenia
title Correlation of hair risperidone concentration and serum level among patients with schizophrenia
title_full Correlation of hair risperidone concentration and serum level among patients with schizophrenia
title_fullStr Correlation of hair risperidone concentration and serum level among patients with schizophrenia
title_full_unstemmed Correlation of hair risperidone concentration and serum level among patients with schizophrenia
title_short Correlation of hair risperidone concentration and serum level among patients with schizophrenia
title_sort correlation of hair risperidone concentration and serum level among patients with schizophrenia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551431/
https://www.ncbi.nlm.nih.gov/pubmed/31179425
http://dx.doi.org/10.1136/gpsych-2018-100042
work_keys_str_mv AT sunxiujia correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT wanglihua correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT yangfuzhong correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT renjuanjuan correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT jiangping correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT liuhongmei correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT lihuafang correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT lichunbo correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia
AT zhangchen correlationofhairrisperidoneconcentrationandserumlevelamongpatientswithschizophrenia